Multitask Learning-Driven Identification of Novel Antitrypanosomal Compounds

References

• Ponte-Sucre A . An overview of trypanosoma brucei infections: an intense host–parasite interaction. Front. Microbiol.7, 2126 (2016).
   PubMed Web of Science ®Google Scholar
• Büscher P , CecchiG , JamonneauV , PriottoG. Human African trypanosomiasis. Lancet390(10110), 2397–2409 (2017).
   PubMed Web of Science ®Google Scholar
• Kioy D , JanninJ , MattockN. Focus: human African trypanosomiasis. Nat. Rev. Microbiol.2(3), 186 (2004).
   PubMed Web of Science ®Google Scholar
• Pérez-Molina JA , MolinaI. Chagas disease. Lancet391(10115), 82–94 (2018).
   PubMed Web of Science ®Google Scholar
• Clayton J . Chagas disease 101. Nature465(Suppl. 7301), S4–S5 (2010).
   PubMed Web of Science ®Google Scholar
• Ribeiro AL , NunesMP , TeixeiraMM , RochaMOC. Diagnosis and management of Chagas disease and cardiomyopathy. Nat. Rev. Cardiol.9(10), 576–589 (2012).
   PubMed Web of Science ®Google Scholar
• Bonney KM , LuthringerDJ , KimSA , GargNJ , EngmanDM. Pathology and pathogenesis of Chagas heart disease. Ann. Rev. Pathol.14(1), 421–447 (2019).
   PubMedGoogle Scholar
• Tanowitz HB , MachadoFS , SprayDCet al. Developments in the management of Chagas cardiomyopathy. Expert Rev. Cardiovasc. Ther.13(12), 1393–1409 (2015).
   PubMed Web of Science ®Google Scholar
• Matsuda NM , MillerSM , EvoraPRB. The chronic gastrointestinal manifestations of Chagas disease. Clinics64(12), 1219–1224 (2009).
   PubMed Web of Science ®Google Scholar
• De Rycker M , WyllieS , HornD , ReadKD , GilbertIH. Anti-trypanosomatid drug discovery: progress and challenges. Nat. Rev. Microbiol.21(1), 35–50 (2023).
   PubMed Web of Science ®Google Scholar
• Malone CJ , NevisI , FernándezE , SanchezA. A rapid review on the efficacy and safety of pharmacological treatments for Chagas disease. Trop. Med. Infect. Dis.6(3), 128 (2021).
   PubMedGoogle Scholar
• Nunes MCP , BeatonA , AcquatellaHet al. Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American Heart Association. Circulation138(12), e169–e209 (2018).
   PubMed Web of Science ®Google Scholar
• Crespillo-Andújar C , ComecheB , HamerDHet al. Use of benznidazole to treat chronic Chagas disease: an updated systematic review with a meta-analysis. PLOS Negl. Trop. Dis.16(5), e0010386 (2022).
   PubMed Web of Science ®Google Scholar
• Bernhard S , KaiserM , BurriC , MäserP. Fexinidazole for human African trypanosomiasis, the fruit of a successful public-private partnership. Diseases10(4), 90 (2022).
   PubMedGoogle Scholar
• Deeks ED . Fexinidazole: first global approval. Drugs79(2), 215–220 (2019).
   PubMed Web of Science ®Google Scholar
• Field MC , HornD , FairlambAHet al. Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need. Nat. Rev. Microbiol.15(4), 217–231 (2017).
   PubMed Web of Science ®Google Scholar
• Campos MCO , LeonLL , TaylorMC , KellyJM. Benznidazole-resistance in Trypanosoma cruzi: evidence that distinct mechanisms can act in concert. Mol. Biochem. Parasitol.193(1), 17–19 (2014).
   PubMed Web of Science ®Google Scholar
• Baker N , de KoningHP , MäserP , HornD. Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story. Trends Parasitol.29(3), 110–118 (2013).
   PubMed Web of Science ®Google Scholar
• Neves BJ , BragaRC , Melo-FilhoCC , Moreira-FilhoJT , MuratovEN , AndradeCH. QSAR-based virtual screening: advances and applications in drug discovery. Front. Pharmacol.9(November), 1–7 (2018).
   PubMedGoogle Scholar
• Stokes JM , YangK , SwansonKet al. A deep learning approach to antibiotic discovery. Cell180(4), 688–702 (2020).
   PubMed Web of Science ®Google Scholar
• Anantpadma M , LaneT , ZornKMet al. Ebola virus Bayesian machine learning models enable new in vitro leads. ACS Omega4(1), 2353–2361 (2019).
   PubMed Web of Science ®Google Scholar
• Mater AC , CooteML. Deep learning in chemistry. J. Chem Inf. Model.59(6), 2545–2559 (2019).
   PubMed Web of Science ®Google Scholar
• Zeng X , WangF , LuoYet al. Deep generative molecular design reshapes drug discovery. Cell Rep. Med.3(12), 100794 (2022).
   PubMedGoogle Scholar
• Li Z , JiangM , WangS , ZhangS. Deep learning methods for molecular representation and property prediction. Drug Discov. Today27(12), 103373 (2022).
   PubMed Web of Science ®Google Scholar
• Moreira-Filho JT , da SilvaMFB , BorbaJVVBet al. Artificial intelligence systems for the design of magic shotgun drugs. Artif. Intell.Life Sci.3, 100055 ( 2023).
   Google Scholar
• Neves BJ , BragaRC , AlvesVMet al. Deep learning-driven research for drug discovery: tackling malaria. PLOS Comput. Biol.16(2), e1007025 (2020).
   PubMed Web of Science ®Google Scholar
• Sun T , ShaoY , LiXet al. Learning sparse sharing architectures for multiple tasks. Proc. AAAI Conf. Artif. Intell.34(05), 8936–8943 (2020).
   Google Scholar
• Lee S , LeeR , SeoMet al. Multi-task learning with task-specific feature filtering in low-data condition. Electronics (Basel)10(21), 2691 (2021).
   Web of Science ®Google Scholar
• Simões RS , MaltarolloVG , OliveiraPR , HonorioKM. Transfer and multi-task learning in QSAR modeling: advances and challenges. Front. Pharmacol.9, 74 (2018).
   PubMed Web of Science ®Google Scholar
• Sosnin S , VashurinaM , WithnallM , KarpovP , FedorovM , TetkoIV. A survey of multi-task learning methods in chemoinformatics. Mol. Inform.38(4), e1800108 (2019).
   PubMed Web of Science ®Google Scholar
• Gaulton A , BellisLJ , BentoAPet al. ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res.40(Database issue), D1100–D1107 (2012).
   PubMed Web of Science ®Google Scholar
• Katsuno K , BurrowsJN , DuncanKet al. Hit and lead criteria in drug discovery for infectious diseases of the developing world. Nat. Rev. Drug Discov.14(11), 751–758 (2015).
   PubMed Web of Science ®Google Scholar
• Fourches D , MuratovE , TropshaA , FourchersD , MuratovE , TropshaA. Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research. J. Chem. Inf. Model.50(7), 1189–1204 (2010).
   PubMed Web of Science ®Google Scholar
• Fourches D , MuratovE , TropshaA. Trust, but verify II: a practical guide to chemogenomics data curation. J. Chem. Inf. Model.56(7), 1243–1252 (2016).
   PubMed Web of Science ®Google Scholar
• Fourches D , MuratovE , TropshaA. Curation of chemogenomics data. Nat. Chem. Biol.11(8), 535 (2015).
   PubMed Web of Science ®Google Scholar
• Landrum G . RDKit: open-source cheminformatics software (2020). www.rdkit.org/
   Google Scholar
• Python Software Foundation . Python language reference (2020). www.python.org
   Google Scholar
• Lounkine E , WawerM , WassermannAM , BajorathJ. SARANEA: a freely available program to mine structure-activity and structure-selectivity relationship information in compound data sets. J. Chem. Inf. Model.50(1), 68–78 (2010).
   PubMed Web of Science ®Google Scholar
• Wawer M , PeltasonL , WeskampN , TeckentrupA , BajorathJ. Structure-activity relationship anatomy by network-like similarity graphs and local structure-activity relationship indices. J. Med. Chem.51(19), 6075–6084 (2008).
   PubMed Web of Science ®Google Scholar
• Yang K , SwansonK , JinWet al. Analyzing learned molecular representations for property prediction. J. Chem. Inf. Model.59(8), 3370–3388 (2019).
   PubMed Web of Science ®Google Scholar
• Gilmer J , SchoenholzSS , RileyPF , VinyalsO , DahlGE. Neural message passing for quantum chemistry. Proc. Int. Conf. Mach. Learn.70, 1263–1272 (2017).
   Google Scholar
• Abadi M , BarhamP , ChenJet al. TensorFlow: a system for large-scale machine learning. In: 12th USENIX Symposium on Operating Systems Design and Implementation (OSDI ‘16).ArXiv, GA, USA, 265–284 (2016).
   Google Scholar
• Lundberg SM , LeeSI. A unified approach to interpreting model predictions. In: NIPS'17: Proceedings of the 31st International Conference on Neural Information Processing Systems.ArXiv, CA, USA, 4766–4775 (2017).
   Google Scholar
• Rodríguez-Pérez R , BajorathJ. Interpretation of compound activity predictions from complex machine learning models using local approximations and Shapley values. J. Med. Chem.63(16), 8761–8777 (2020).
   PubMed Web of Science ®Google Scholar
• Rodríguez-Pérez R , BajorathJ. Interpretation of machine learning models using Shapley values: application to compound potency and multi-target activity predictions. J. Comput. Aided Mol. Des.34(10), 1013–1026 (2020).
   PubMed Web of Science ®Google Scholar
• Cranmer SL , MagowanC , LiangJ , CoppelRL , CookeBM. An alternative to serum for cultivation of Plasmodium falciparum in vitro. Trans. R. Soc. Trop. Med. Hyg.91(3), 363–365 (1997).
   PubMed Web of Science ®Google Scholar
• Trager W , JensenJB. Human malaria parasites in continuous culture. Science193(4254), 673–675 (1976).
   PubMed Web of Science ®Google Scholar
• Lambros C , VanderbergJP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol.65(3), 418–420 (1979).
   PubMed Web of Science ®Google Scholar
• Räz B , ItenM , Grether-BühlerY , KaminskyR , BrunR. The Alamar Blue® assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro. Acta Trop.68(2), 139–147 (1997).
   PubMed Web of Science ®Google Scholar
• Charneau S , de MesquitaML , BastosIMDet al. In vitro investigation of Brazilian cerrado plant extract activity against Plasmodium falciparum, Trypanosoma cruzi and T. brucei gambiense. Nat. Prod. Res.30(11), 1320–1326 (2016).
   PubMed Web of Science ®Google Scholar
• Cordeiro TM , BorghettiF , CaldasOliveira Set al. Brazilian cerrado Qualea grandiflora Mart. leaves exhibit antiplasmodial and trypanocidal activities in vitro. Pharmacogn. Mag.13(52), 668 (2017).
   PubMed Web of Science ®Google Scholar
• Smilkstein M , SriwilaijaroenN , KellyJX , WilairatP , RiscoeM. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob. Agents Chemother.48(5), 1803–1806 (2004).
   PubMed Web of Science ®Google Scholar
• Stumpfe D , BajorathJ. Exploring activity cliffs in medicinal chemistry. J. Med. Chem.55(7), 2932–2942 (2012).
   PubMed Web of Science ®Google Scholar
• Torrico F , GasconJ , OrtizLet al. Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial. Lancet Infect. Dis.18(4), 419–430 (2018).
   PubMed Web of Science ®Google Scholar
• Molina I , Gómezi Prat J , SalvadorFet al. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease. N. Engl. J. Med.370(20), 1899–1908 (2014).
   PubMed Web of Science ®Google Scholar
• Phillips MA , BurrowsJN , ManyandoC , van HuijsduijnenRH , Van VoorhisWC , WellsTNC. Malaria. Nat. Rev. Dis. Primers3(1), e0004300 (2017).
   Google Scholar
• Jiménez-Luna J , GrisoniF , SchneiderG. Drug discovery with explainable artificial intelligence. Nat. Mach. Intell.2(10), 573–584 (2020).
   Google Scholar
• Feldmann C , PhilippsM , BajorathJ. Explainable machine learning predictions of dual-target compounds reveal characteristic structural features. Sci. Rep.11(1), 1–11 (2021).
   PubMed Web of Science ®Google Scholar